News & Analysis on the Clinical Development and Manufacture of Large Molecule Drugs
Biopharma is ramping up the outsourcing of some of the easier tests while tasks such as downstream process development and QbD services are being outsourced less, according to a new survey.
Sartorius Stedim Biotech has acquired a majority stake in single-use systems start-up firm AllPure Technologies.
Increased demand for mammalian technologies will boost Lonza further when a new Swiss facility comes online offering “unique” complete development and manufacturing ADC services, the firm says.